Technology

Savara

$1.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.09 (+6.62%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Savara and other stocks, options, and ETFs commission-free!

About SVRA

Savara Inc. Common Stock, also called Savara, is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its products include AeroVanc, Molgradex, GM-CSF, and Aironite. The company was founded on April 27, 2017 and is headquartered in Austin, TX. The listed name for SVRA is Savara Inc. Common Stock.

CEO
Matthew Pauls
Employees
39
Headquarters
Austin, Texas
Founded
2017
Market Cap
77.93M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
396.86K
High Today
$1.48
Low Today
$1.30
Open Price
$1.33
Volume
759.47K
52 Week High
$3.95
52 Week Low
$0.9952

Collections

SVRA Earnings

-$0.57
-$0.38
-$0.19
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, After Hours

You May Also Like

WK
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure